America’s biopharmaceutical research companies are investigating or developing 85 medicines to help the more than five million patients in the United States who are living with Alzheimer’s.
have Alzheimer's disease.
cost of Alzheimer's and other dementias in the U.S. in 2017
provide unpaid care for people with Alzheimer's and other dementias
of death in the U.S. is Alzheimer's disease